abstract |
The invention relates to novel compounds of formula (I), wherein D, W, X, Y, T and R<1> have the meanings as cited in Patent Claim 1. These compounds are inhibitors of coagulation factor Xa and can be used for the prevention and/or treatment of thromboembolic diseases and for treating tumors. |